RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE

医疗保险家庭护理中的资源使用和患者结果

基本信息

项目摘要

Medicare-certified home care agencies are under increasing pressure to improve both resource efficiency and quality of care for patients who are insured by the Medicare program. Home care agency clinicians and managers, predominantly nurses, are responding by collecting and reviewing standardized data to monitor resource use and patient outcomes. Yet little scientific knowledge has been produced to explain how outcomes in Medicare home care patients are associated with the amount of clinical staff resources allocated for these patients during home care episodes. Therefore, the long-term objective of this study is to improve our understanding of the complex interplay between resource use and health-related outcomes in Medicare home care patients with diverse characteristics who are served by a diverse group of Medicare-certified home care agencies. The primary aim of this study is to determine how home care patient outcomes are associated with specific home care resource use measures, controlling for market, home care agency, and patient variables. The secondary aim is to determine the relative importance of market factors, agency characteristics, patient characteristics, and home care resource use in influencing home care patient outcomes. Hypothesis 1: Patients who end an episode of care due to hospitalization will use the same amount of home care resources as patients who end an episode of care and remain at home, but they will show greater service intensity, controlling for market, agency, and patient variables. Hypothesis 2: Patients who decline in functional status during an episode of home care will use the same amount of home care resources as patients who improve in functional status, controlling for market, agency, and patient variables. Hypothesis 3: Patients whose symptoms worsen during an episode of home care will use the same amount of home care resources as patients whose symptoms improve, controlling for market, agency, and patient variables. Hypothesis 4: The observed relationships (direct and indirect effects) between market factors, agency characteristics, home care resource use, and home care patient outcomes will be adequately represented by a structural equation model. Using a prospective cohort study design, we will enroll 1,500 patients from 30 randomly-selected Ohio home care agencies. Patient data will be collected by trained home care staff, based on assessments at the first and final visits of episodes. Information about resource use at every home visit will also be recorded. Data analyses will determine unadjusted and adjusted relationships between measures of resource use and patient outcomes. A Project Advisory Committee will help translate findings into strategies for planning home care resource allocation based on patient outcomes.
经过联邦医疗保险认证的家庭护理机构面临着越来越大的压力 提高以下患者的资源效率和护理质量 都是由医疗保险计划投保的。家庭护理机构临床医生和 管理者,主要是护士,正在通过收集和 审查标准化数据以监控资源使用情况和患者 结果。然而,几乎没有科学知识来解释 医疗保险家庭护理患者的结果如何与 年内分配给这些病人的临床人力资源量 家庭护理插曲。因此,这项研究的长期目标是 是为了提高我们对两者复杂相互作用的理解 医疗保险家庭护理患者的资源使用和健康相关结果 具有不同的特征,由不同的 医疗保险认证的家庭护理机构。这项研究的主要目的是 是确定家庭护理患者的结果如何与 具体的家庭护理资源使用措施,控制市场,家庭 护理机构和患者变量。次要目标是确定 市场因素的相对重要性,中介机构的特点, 患者特征和家庭护理资源使用对家庭的影响 关心病人的结果。假设1:结束一段护理的患者 由于住院将使用相同数量的家庭护理资源 作为结束一段时间的护理并留在家里的患者,但他们会 展示更大的服务强度,控制市场、代理和 病人的变数。假设2:功能衰退的患者 在一次家庭护理期间的状态将使用相同数量的家庭 作为改善功能状态的患者的护理资源,控制 针对市场、机构和患者变量。假设3:患者的 在家庭护理的一次发作期间症状恶化将使用相同的量 作为症状改善、控制的患者的家庭护理资源 针对市场、机构和患者变量。假设4:观察到的 市场因素之间的关系(直接和间接影响), 机构特征、家庭护理资源使用与家庭护理患者 结果将由结构方程模型充分表示。 采用前瞻性队列研究设计,我们将招募1500名患者 来自俄亥俄州随机挑选的30家家庭护理机构。患者数据将被 由训练有素的家庭护理人员根据最初的评估收集 和最后一集的访问。有关资源使用情况的信息 家访也将被记录下来。数据分析将确定 资源使用衡量标准之间未调整和已调整的关系 和病人的结果。一个项目咨询委员会将帮助翻译 规划居家护理资源分配策略的研究结果 根据患者的治疗结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard H Fortinsky其他文献

Real-World Insights Into Dementia Diagnosis Trajectory and Clinical Practice Patterns Unveiled by Natural Language Processing: Development and Usability Study
通过自然语言处理揭示的痴呆症诊断轨迹和临床实践模式的真实世界见解:开发和可用性研究
  • DOI:
    10.2196/65221
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    4.800
  • 作者:
    Hunki Paek;Richard H Fortinsky;Kyeryoung Lee;Liang-Chin Huang;Yazeed S Maghaydah;George A Kuchel;Xiaoyan Wang
  • 通讯作者:
    Xiaoyan Wang

Richard H Fortinsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard H Fortinsky', 18)}}的其他基金

Data Core RC2
数据核心 RC2
  • 批准号:
    10294031
  • 财政年份:
    2021
  • 资助金额:
    $ 40.96万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10294028
  • 财政年份:
    2021
  • 资助金额:
    $ 40.96万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10668310
  • 财政年份:
    2021
  • 资助金额:
    $ 40.96万
  • 项目类别:
Data Core RC2
数据核心 RC2
  • 批准号:
    10668322
  • 财政年份:
    2021
  • 资助金额:
    $ 40.96万
  • 项目类别:
Impact of AD/ADRD on Health-Related Outcomes in a Statewide Population Enrolled in a Publicly-Funded HCBS Waiver Program for Older Adults
AD/ADRD 对参加公共资助的老年人 HCBS 豁免计划的全州人口健康相关结果的影响
  • 批准号:
    10095054
  • 财政年份:
    2020
  • 资助金额:
    $ 40.96万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    9105676
  • 财政年份:
    2014
  • 资助金额:
    $ 40.96万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8696260
  • 财政年份:
    2014
  • 资助金额:
    $ 40.96万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8895825
  • 财政年份:
    2014
  • 资助金额:
    $ 40.96万
  • 项目类别:
Proactive Primary Dementia Care
积极主动的原发性痴呆护理
  • 批准号:
    7897932
  • 财政年份:
    2009
  • 资助金额:
    $ 40.96万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6187610
  • 财政年份:
    1999
  • 资助金额:
    $ 40.96万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.96万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 40.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了